Skip to content

The Paediatric Virtual Autopsy Trial

Post-mortem Cross-sectional Imaging With Guided Biopsy; A Comparative Study With Conventional Autopsy in Foetuses, Neonates, Infants and Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01888380
Enrollment
105
Registered
2013-06-27
Start date
2014-01-01
Completion date
2018-08-31
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newborn Death, Stillbirth, Sudden Infant Death

Keywords

Autopsy, Minimally invasive, Foetuses, Newborns, Children, Adolescents

Brief summary

In light of declining autopsy rates around the world, post-mortem MR imaging is a promising alternative to conventional autopsy in the investigation of infant death. A major drawback of this non-invasive autopsy approach is the fact that histopathological and microbiological examination of the tissue is not possible. The objective of this prospective study is to compare the performance of minimally invasive, virtual autopsy, including CT-guided biopsy, with conventional autopsy procedures in a paediatric population. Foetuses, newborns, infants and children that are referred for autopsy at three different institutions associated with the University of Zurich will be eligible for recruitment. All bodies will be examined with a commercial CT and a 3 Tesla MRI scanner, and investigators will be blinded to the results of conventional autopsy. After cross-sectional imaging, CT-guided tissue sampling will be performed by a multifunctional robotic system (Virtobot) allowing for automated post-mortem biopsies. Virtual autopsy results will be classified with regards to the likely final diagnosis and major pathological findings and compared to the results of conventional autopsy, which remains the diagnostic gold standard. This interdisciplinary study will determine whether virtual autopsy will narrow the gap in information between non-invasive and traditional autopsy procedures.

Interventions

PROCEDUREMinimally invasive, virtual autopsy

Post-mortem cross-sectional imaging with CT-guided biopsy

PROCEDUREConventional autopsy

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 16 Years
Healthy volunteers
No

Inclusion criteria

* Stillborn infants ≥ 16 0/7 weeks of gestational age (GA) * Live born infants ≥ 16 0/7 weeks GA until adolescents up to 16 years of age, who died of natural- and non-natural cause (trauma, homicide, suicide and intoxication).

Exclusion criteria

* Deceased infants who are donors of organs * Lack of parental consent

Design outcomes

Primary

MeasureTime frameDescription
Percentage of cases for which virtual autopsy correctly identifies the cause of death and/or major pathological lesions8 weeksThe diagnoses established in both ways by the two independent teams will be compared, the autopsy results being the gold standard. The primary outcome will be the percentage of cases for which virtual autopsy correctly identifies the diagnostic category.

Secondary

MeasureTime frameDescription
Clinical indication8 weeksNumber of false positive and false negative results of virtual autopsy will be calculated for each organ system.
MR Protocol8 weeksTo optimize a protocol for MR imaging examinations in deceased foetuses, neonates, infants and children
Change in the ante-mortem diagnosis8 weeksThe proportion of cases, for which virtual autopsy leaded to a change in ante-mortem diagnosis, will be reported.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026